New Delhi: Drug firm Cipla on Tuesday said it has received observations from the US health regulator for its Goa plant which are procedural in nature. The United States Food and Drug Administration ...

https://www.thehindubusinessline.com/markets/cipla-stock-rises-nearly-2-after-usfda-grants-vai-status-to-goa-plant/article68828574.ece Copy Shares of Cipla gained ...

Cipla share price fell to a fresh 52-week low after the company received 12 observations by USFDA for its manufacturing facility in Goa. "United States Food and Drug Administration (USFDA) conducted a ...

The US FDA has issued a warning letter (WL) to Cipla’s Goa plant with regard to GMP deviations noted during a facility inspection conducted in September 2019. The FDA had earlier issued an OAI ...

Learn about Cipla Ltd in Goa.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are associated with Cipla Ltd and want ...

"United States Food and Drug Administration recently concluded audit of our three manufacturing facilities in Goa and has issued four observations across these three facilities," Cipla said in a ...

Panaji: After coming under fire for planning a recruitment drive in Vapi, Gujarat, for vacancies at its Goa production facility, Cipla Ltd announced that due to “business exigencies” it has cancelled ...

Cipla share price today: The pharma major reported a 49% increase in net profit, reaching Rs 1,571 crore (Image: Reuters) Cipla shares soared 10% to an intraday high of Rs 1,560.05 after USFDA ...

At this stage, the company does not foresee any impact on the other products being manufactured/filed from the plant, Cipla said. "We received certain observations which are procedural in nature. We ...